Webcast overview
In this webcast professionals from KPMG, J.P. Morgan, and Nasdaq provide their insights and perspectives on the IPO market for the life sciences industry.
Topics discussed on this webcast include:
- Capital markets update for the life sciences industry
- Impact of COVID-19 on the life sciences ecosystem
- IPO market dynamics: potential “IPO windows” for the balance of 2020, the virtual IPO roadshow, and investor risk tolerance for new issuance
- Guidance for leaders at both late-stage life sciences companies (who hope to IPO in 2020) and early-stage life sciences companies (who are interested in an IPO down the road)
Featured speakers
Janet Lehman
Required fields
Email me
Partner, Audit, U.S. Venture Capital Life Sciences Leader, KPMG US
Jordan Saxe
Required fields
Email me
Senior Managing Director, Head of Healthcare, Capital Markets, Nasdaq
Related content
